Pfizer Resolves Promosome Patent Lawsuit Over COVID-19 Vaccine

Pfizer, BioNTech and biotech firm Promosome have agreed to end Promosome's lawsuit accusing the COVID-19 vaccine makers of infringing a patent related to messenger RNA technology.
Reuters Health Information

source https://www.medscape.com/s/viewarticle/997111?src=rss